Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Originclear (OCLN) Research & Development (2016 - 2020)

Originclear (OCLN) has disclosed Research & Development for 11 consecutive years, with $26937.0 as the latest value for Q4 2020.

  • On a quarterly basis, Research & Development fell 1.17% to $26937.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $110338.0, a 2.78% increase, with the full-year FY2020 number at $110338.0, up 2.78% from a year prior.
  • Research & Development was $26937.0 for Q4 2020 at Originclear, down from $29334.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $210150.0 in Q1 2016 to a low of $23950.0 in Q1 2019.
  • A 5-year average of $60377.9 and a median of $46709.5 in 2018 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: plummeted 77.81% in 2017, then soared 157.07% in 2018.
  • Originclear's Research & Development stood at $55176.0 in 2016, then grew by 9.72% to $60537.0 in 2017, then skyrocketed by 102.52% to $122598.0 in 2018, then tumbled by 77.77% to $27257.0 in 2019, then dropped by 1.17% to $26937.0 in 2020.
  • Per Business Quant, the three most recent readings for OCLN's Research & Development are $26937.0 (Q4 2020), $29334.0 (Q3 2020), and $25085.0 (Q2 2020).